These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5. Haworth B, Lin H, Fidock M, Dorr P, Strange PG. Biochem Pharmacol; 2007 Sep 15; 74(6):891-7. PubMed ID: 17669370 [Abstract] [Full Text] [Related]
6. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists. Carter PH, Tebben AJ. Methods Enzymol; 2009 Sep 15; 461():249-79. PubMed ID: 19480923 [Abstract] [Full Text] [Related]
9. Drug discovery and chemokine receptor antagonists: eppur si muove! Terricabras E, Benjamim C, Godessart N. Autoimmun Rev; 2004 Nov 15; 3(7-8):550-6. PubMed ID: 15546804 [Abstract] [Full Text] [Related]
12. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Springael JY, Le Minh PN, Urizar E, Costagliola S, Vassart G, Parmentier M. Mol Pharmacol; 2006 May 15; 69(5):1652-61. PubMed ID: 16467191 [Abstract] [Full Text] [Related]
18. Regulation of chemokine activity by posttranslational modification. Mortier A, Van Damme J, Proost P. Pharmacol Ther; 2008 Nov 15; 120(2):197-217. PubMed ID: 18793669 [Abstract] [Full Text] [Related]
19. Chemokine receptors: attractive targets for drug discovery. Godessart N. Ann N Y Acad Sci; 2005 Jun 15; 1051():647-57. PubMed ID: 16127005 [Abstract] [Full Text] [Related]